Genhtis
2 known investors
Find your way into Genhtis
Sign up to see every warm intro you have to Genhtis
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Genhtis team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Genhtis builds domestic and allied-nation manufacturing capacity for critical pharmaceuticals, controlling the full supply chain from raw input to finished product with modular, scalable production and end-to-end traceability. It targets Western healthcare systems, hospitals, and governments, starting with heparin, to reduce dependency on concentrated global supply chains.
Investors · 2
Deep Checksreported$100K – $500Kvia Julian Shapiro · inferred
How we know: the VCSheet dataset · Not right? Tell us
Frequently asked questions
- What does Genhtis do?
- Genhtis builds domestic and allied-nation manufacturing capacity for critical pharmaceuticals, controlling the full supply chain from raw input to finished product with modular, scalable production and end-to-end traceability. It targets Western healthcare systems, hospitals, and governments, starting with heparin, to reduce dependency on concentrated global supply chains.
- Who are Genhtis's investors?
- Genhtis's investors include Adeline, Deep Checks.
